ARHGAP1 overexpression inhibits proliferation, migration and invasion of C-33A and SiHa cell lines

References

• BrooksSEChenTTGhoshAMullinsCDGardnerJFBaquetCRCervical cancer outcomes analysis: impact of age, race, and comorbid illness on hospitalizations for invasive carcinoma of the cervixGynecol Oncol200079110711511006041
   PubMedGoogle Scholar
• NewmannSJGarnerEOSocial inequities along the cervical cancer continuum: a structured reviewCancer Causes Control2005161637015750859
   PubMed Web of Science ®Google Scholar
• KandpalRPRho GTPase activating proteins in cancer phenotypesCurr Protein Pept Sci20067435536516918449
   PubMed Web of Science ®Google Scholar
• Etienne-MannevilleSHallARho GTPases in cell biologyNature2002420691662963512478284
   PubMed Web of Science ®Google Scholar
• JohnstoneCNCastellví-BelSChangLMARHGAP8 is a novel member of the RHOGAP family related to ARHGAP1/CDC42GAP/p50RHOGAP: mutation and expression analyses in colorectal and breast cancersGene20043361597115225876
   PubMedGoogle Scholar
• XuJZhouXWangJRhoGAPs attenuate cell proliferation by direct interaction with p53 tetramerization domainCell Rep2013351526153823684608
   PubMedGoogle Scholar
• WongCMYamJWPChingYPRho GTPase-activating protein deleted in liver cancer suppresses cell proliferation and invasion in hepatocellular carcinomaCancer Res200565198861886816204057
   PubMedGoogle Scholar
• ChingYPWongCMChanSFDeleted in liver cancer (DLC) 2 encodes a RhoGAP protein with growth suppressor function and is underexpressed in hepatocellular carcinomaJ Biol Chem200327812108241083012531887
   PubMedGoogle Scholar
• LiaoYCLoSHDeleted in liver cancer-1 (DLC-1): a tumor suppressor not just for liverInt J Biochem Cell Biol200840584384717521951
   PubMedGoogle Scholar
• RosenthalDTBrennerJCMerajverSDRho proteins in cancervan GolenKLRho GTPases CancerNew York, NYSpringer New York20102942
   Google Scholar
• AhnY-HGibbonsDLChakravartiDZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expressionJ Clin Invest201212293170318322850877
   PubMed Web of Science ®Google Scholar
• BarfodEZhengYKuangWCloning and expression of a human CDC42 GTPase-activating protein reveals a functional SH3-binding domainJ Biol Chem19932683526059260628253717
   PubMedGoogle Scholar
• RidleyAJSelfAJKasmiFrho family GTPase activating proteins p190, bcr and rhoGAP show distinct specificities in vitro and in vivoEMBO J1993121351518262058
   PubMedGoogle Scholar
• ZhangBZhengYRegulation of RhoA GTP hydrolysis by the GTPase-activating proteins p190, p50RhoGAP, Bcr, and 3BP-1Biochemistry19983715524952579548756
   PubMedGoogle Scholar
• OuchidaMKanzakiHItoSNovel direct targets of miR-19a identified in breast cancer cells by a quantitative proteomic approachPLoS One201278e4409522952885
   PubMedGoogle Scholar
• GarrettMDSelfAJvan OersCHallAIdentification of distinct cytoplasmic targets for ras/R-ras and rho regulatory proteinsJ Biol Chem1989264110132491843
   PubMedGoogle Scholar
• LancasterCATaylor-HarrisPMSelfAJBrillSvan ErpHEHallACharacterization of rhoGAP. A GTPase-activating protein for rho-related small GTPasesJ Biol Chem19942692113711428288572
   PubMedGoogle Scholar
• VegaFMRidleyAJRho GTPases in cancer cell biologyFEBS Lett2008582142093210118460342
   PubMed Web of Science ®Google Scholar
• NagarajaGMKandpalRPChromosome 13q12 encoded Rho GTPase activating protein suppresses growth of breast carcinoma cells, and yeast two-hybrid screen shows its interaction with several proteinsBiochem Biophys Res Commun2004313365466514697242
   PubMedGoogle Scholar
• PeckJDouglasG4thWuCHBurbeloPDHuman RhoGAP domain-containing proteins: structure, function and evolutionary relationshipsFEBS Lett20025281–3273412297274
   PubMedGoogle Scholar
• HoleiterGBischoffABraunAThe RhoGAP protein deleted in liver cancer 3 (DLC3) is essential for adherens junctions integrityOncogenesis20121e1323552697
   PubMed Web of Science ®Google Scholar
• LiuZXuYZhangXSongJSorokinLBählerMThe motorized RhoGAP myosin IXb (Myo9b) in leukocytes regulates experimental autoimmune encephalomyelitis induction and recoveryJ Neuroimmunol2015282253225903725
   PubMedGoogle Scholar
• RanJLinDLWuRFZEB1 promotes epithelial-mesenchymal transition in cervical cancer metastasisFertil Steril201510361606161425963537
   PubMed Web of Science ®Google Scholar
• YuanJYanRKrämerACyclin B1 depletion inhibits proliferation and induces apoptosis in human tumor cellsOncogene200423345843585215208674
   PubMed Web of Science ®Google Scholar
• YuanJKrämerAMatthessYStable gene silencing of cyclin B1 in tumor cells increases susceptibility to taxol and leads to growth arrest in vivoOncogene200625121753176216278675
   PubMedGoogle Scholar
• SunZZhangDCuiYChengLCaoJWuXResearch on chemotherapy efficacy of twist gene on cervical cancer cells to paclitaxelPak J Pharm Sci2014275 suppl1713171825262524
   PubMedGoogle Scholar
• MitraAChakrabartiJChattopadhyayNChatterjeeAMembrane-associated MMP-2 in human cervical cancerJ Environ Pathol Toxicol Oncol20032229310014533872
   PubMedGoogle Scholar
• MitraAChakrabartiJBanerjiADasSChatterjeeACulture of human cervical cancer cells, SiHa, in the presence of fibronectin activates MMP-2J Cancer Res Clin Oncol2006132850551316788844
   PubMedGoogle Scholar
• MorozADelellaFKAlmeidaRFinasteride inhibits human prostate cancer cell invasion through MMP2 and MMP9 downregulationPLoS One2013812e8475724386413
   PubMedGoogle Scholar
• SoiniYTuhkanenHSironenRTranscription factors zeb1, twist and snai1 in breast carcinomaBMC Cancer201111121194487
   PubMedGoogle Scholar
• MerikallioHKaarteenahoRPääkköPZeb1 and twist are more commonly expressed in metastatic than primary lung tumours and show inverse associations with claudinsJ Clin Pathol201164213614021131312
   PubMedGoogle Scholar
• ShibataKKajiyamaHInoKTwist expression in patients with cervical cancer is associated with poor disease outcomeAnn Oncol2008191818517925286
   PubMedGoogle Scholar
• BrancaMCiottiMGiorgiCHPV-PathogenISS Study GroupUp-regulation of proliferating cell nuclear antigen (PCNA) is closely associated with high-risk human papillomavirus (HPV) and progression of cervical intraepithelial neoplasia (CIN), but does not predict disease outcome in cervical cancerEur J Obstet Gynecol Reprod Biol2007130222323117098349
   PubMed Web of Science ®Google Scholar
• AstudilloHPerezMSilvaJP53, Bcl-2, PCNA expression and apoptotic rates during cervical tumorigenesisAnn N Y Acad Sci2003101077177415033825
   PubMedGoogle Scholar